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Abstract
Background: Small bowel tumours are rare and comprise less than 2 % of all primary gastrointestinal neoplasms.
Among these tumours, a leiomyosarcoma belonging to soft tissue sarcomas is extremely rare and accounts for
about 1 % of malignant mesenchymal lesions in the gastrointestinal tract. Due to its aggressive nature and slow
growth, it is often diagnosed at the late stage when curative treatment is impossible. Authors report a first case of
leiomyosarcoma with chronic recurrent ileocaecal intussusception and literature review to analyse diagnosis and
treatment features of the ileum mesenchymal tumours.
Case presentation: We present a case of an 87-year-old Caucasian man suffering from cramp-like abdominal pain
for months. Due to lack of clinical signs and unspecific complaints, a diagnosis was delayed. Despite a detailed in-
hospital examination, a proper diagnosis was established as late as during an operation. The patient was treated by
surgery with good results. An uncommon laparoscopic resection of the small bowel with a tumour was performed.
A histopathological investigation confirmed a very rare mesenchymal lesion of the distal ileum. The patient is under
control with no recurrence for 1 year of the follow-up period.
Conclusions: Reported case indicates that a usually asymptomatic tumour can cause uncommon chronic recurrent
ileus signs. CT and MRI scans are investigation of choice in such cases, but they are sometimes inconclusive. It
might be worth highlighting the good results of laparoscopic leiomyosarcoma lesion resection with a very good
outcome.
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Background
Abdominal pain is one of the most commonly reported
ailments with no relation to the sex or age. It is often
the first symptom of serious gastrointestinal tract dis-
eases. Differentiation is difficult. Many of reported ab-
dominal pain cases are caused by gastroenteritis or
woman’s diseases. Sometimes, it can be caused by a very
rare disease that shows unspecific signs and has to be
well differentiated for curative treatment.
We present a very rare case of a patient with severe
abdominal pain in the right lower quadrant caused by
intussusception of the small bowel with a leiomyosar-
coma in the caecum with ileocaecal subocclusion.
A leiomyosarcoma (LMS) is a rare smooth muscle ma-
lignant neoplasm which appears mostly in the retroperi-
toneal space, vascular wall (especially of the great veins)
and soft tissues of the lower extremities. It is an excep-
tionally rare tumour of the gastrointestinal tract arising
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in such localisations like the oesophagus, stomach and
small bowel. LMS belongs to a heterogeneous group of
soft tissue neoplasms, and with its aggressive nature, it
often presents local recurrence and visceral metastases.
As in the presented case, clinical manifestation of this
disease, as in other small bowel tumours, is unspecific.
Authors report a very rare case of recurrent intussuscep-
tions with tumour treated by laparoscopy with good re-
sults. To our best knowledge, there is only one
published case of leiomyosarcoma treated by laparo-
scopic resection, but we have not found any papers con-
cerning chronic recurrent intussusception caused by
leiomyosarcoma.
Case presentation
An 87-year-old Caucasian patient, suffering from arterial
hypertension and hepatitis C, was admitted to the surgi-
cal department due to abdominal pain and weight loss
of about 10 % during last 4 months.
For 6 months, the patient had been complaining about
cramp-like abdominal pain in the right lower quadrant
and suprapubic area, vomiting and bloody stools 3–4
times last week. He also noticed that eating, but not
drinking, had exacerbated pain which usually stopped
without using any drugs within 3–4 h. His past medical
history revealed a stomach resection due to a peptic
ulcer with relaparotomy due to bleeding immediately
after an operation and cholecystectomy about 20 years
ago.
On admission, the patient was in a good condition,
with adequate logical responses and without complaints.
No palpable mass in the abdomen was noted during an
examination. Laboratory test revealed WBC 6250/uL,
RBC 4,150,000/uL, PLT 263,000/uL, and low-grade an-
aemia Hb 11.8 g/dL. The cancer antigen levels were nor-
mal: carcinoembryonal antigen (CEA) 2.29 ng/mL
(normal range 0.00–4.30 ng/mL) and CA 19-9 antigen
16.36 IU/mL (normal range 0.00–39.00 IU/mL). A com-
puter tomography (CT) scan confirmed the presence of
two suspected findings in the sixth and eighth liver seg-
ments, deep in the stroma. Results remained unclear,
and magnetic resonance imaging (MRI) was performed
with no conclusion. Neither CT scan nor MRI did not
reveal any evidence of tumour and intussusception prob-
ably due to lack of occlusion signs at the moment. A col-
onoscopy performed revealed a caecal tumour, probably
involving Bauhin’s valve (Fig. 1). A histopathological
examination of samples collected confirmed the pres-
ence of unknown cancer cells.
In accordance with a preoperative diagnosis (a cae-
cal tumour), the patient was qualified for a laparos-
copy in order to perform right hemicolectomy.
During a surgery, intussusception of about 50 cm of
the non-gangrenous small bowel into the caecum was
found (Fig. 2a, b). Liver investigation did not reveal
any signs of metastases as they were localised deep in
stroma due to CT scan results. No other pathologies
including enlarged lymph nodes and distant metasta-
ses were noticed. After bowel elongation, the segment
with a tumour was resected and an extracorporal
end-to-end anastomosis was performed (Fig. 3).
Postoperative histopathological results revealed a
tumour of 5 × 4 × 3.7 cm, C-kit (−), CD34 (−), S100 (−),
actin (+), high mitotic activity—28 figures per 10 HPFs,
and high degree of necrosis (Fig. 4a–d).
The postoperative period was uneventful; no complica-
tions were noticed. The patient, after intensive postoper-
ative rehabilitation, was discharged on day 7, in a good
condition.
After a consultation with an oncologist, patient was
disqualified from adjuvant therapy. Due to hepatitis
C, advanced age and past surgical history, he was also
not qualified for a liver metastases resection.
The 12-month follow-up period completed, and no re-
currence signs were noticed. Liver metastases are stable
in CT imaging tests.
Small bowel tumours (SBT) are rare and comprise less
than 2 % of all primary gastrointestinal (GI) neoplasms
[1, 2]. There are several conditions which seem to be as-
sociated with an increased risk for developing small
bowel malignancies including inflammatory bowel disea-
se—Crohn’s disease, polyposis syndromes, hereditary
non-polyposis colorectal cancer (HNPCC) or caeliac dis-
ease. The highest morbidity for SBT is in the North
America and Europe, related to men in majority.
Twenty-five percent of all cases are malignant [2]. Both
in the USA and Europe, the most common is carcinoid
(37.4 %) and adenocarcinoma (36.9 %) that occurs two
to three times more frequently than lymphangioma
(17.3 %) and stromal tumours (8.4 %) [3].
Fig. 1 Jejunal tumour invaginated into the caecum—endoscopic view
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LMS is a rare smooth muscle malignant neoplasm and
belongs to soft tissue sarcomas (STS). In late 1990s, due
to the introduction of new immunoassay tests, there were
changes in the classification of GI mesenchymal tumours,
and currently, most of them are classified as
gastrointestinal stromal tumours (GIST). Primary leio-
myosarcomas are diagnosed rarely. These are aggressive
neoplasms often with severe cellular atypia and numerous
mitoses. Definitive tools allowing for differentiation leio-
myosarcoma from GIST are actin and desmin positive
Fig. 2 a Intussusception of the non-gangrenous small bowel into the caecum. b Intussusception of the non-gangrenous small bowel into the caecum
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reactivity, CD117, CD34 and PDGFRA (platelet-derived
growth factor receptor-alfa) negativity. According to 2013
Protocol for the Examination of Specimens from Patients
With Gastrointestinal Stromal Tumor (GIST) that we
based our diagnosis on, stainings listed above were done
in the specimen obtained from our patient [4, 5] (http://
www.cap.org/apps/docs/committees/cancer/cancer_proto-
cols/2013/GIST_13protocol_3022.pdf). DOG1, chloride
channel protein named “Discovered-On-GIST 1”, was
published as a useful tool in GIST differentiation but was
not listed in our local protocols in the time of diagnosis
[6–9]. It was added to the list of immunohistochemical
Fig. 3 End-to-end anastomosis after resection—laparoscopic view
Fig. 4 Histopathological results. a Spindle cell tumour with marked pleomorphism, HE stain, mag. ×100. b Brisk mitotic activity, HE stain, mag. ×200.
c Focal necrosis, HE stain, mag. ×100. d Tumour shows positive immunoreactivity for smooth muscle actin
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studies in recommendations published in 2014 by College
of American Pathologists [9] (http://www.cap.org/Show-
Property?nodePath=/UCMCon/Contribution%20Folders/
WebContent/pdf/cp-gist-14protocol.pdf).
The incidence of primary leiomyosarcoma in the
gastrointestinal tract accounts for 0.1–3 % and that is fif-
tieth that of GIST [5, 10].
Many publications confirm rarity of the disease. In
meta-analysis of the English literature in years 2002–
2012 published by Aggarwal et al., authors noticed only
26 cases of small bowel leiomyosarcomas [4]. Also, after
a retrospective analysis of 262 cases of GI mesenchymal
lesions diagnosed in one centre in the period of 12 years,
Agaimy et al. confirmed three cases of LMS which ac-
count for only 1.1 % [11].
Although most leiomyosarcomas are sporadic neo-
plasms, several aetiologic factors have been deter-
mined. LMSs more commonly occur in patients with
a history of retinoblastoma, HIV infections, immuno-
compromised patients after transplantations and chil-
dren with congenital immunodeficiency. Tumours
have also been found to be associated with Epstein-
Barr virus (EBV) as a nuclear antigen-2 protein and
specific EBV receptor in smooth muscle cells are
expressed in immunocompromised individuals [4].
Generally, STS prognosis is poor; the median overall
survival is about 12 months [9]. A 5-year survival rate in
patients with tumours over 5 cm in diameter and high
mitotic activity is from 5 to 27 % [12, 13].
Several histologic grading systems have been vali-
dated in soft tissue sarcomas, including LMSs; but no
system is currently accepted worldwide. According to
the World Health Organisation (WHO), the grading
of sarcomas should be performed using the US Na-
tional Institute of Health (NIH) or French Federation
Nationale des Centres de Lutte Contre le Cancer
(FNCLCC) grading systems. The ‘French system’ eval-
uates three tumour parameters: a degree of tumour
differentiation, number of mitotic figures per 10 HPFs
and a degree of tumour necrosis. The American sys-
tem uses a histological diagnosis coupled with a de-
gree of cellularity, cellular polymorphism and mitotic
activity. A degree of necrosis is also identified, and a
result greater than 15 % diminishes the prognosis. It
has been demonstrated that the FNCLCC results
show a better correlation with overall and metastasis-
free survival [4, 14].
Due to late clinical manifestation, tumours are diag-
nosed rather late when subileal or GI perforation has
already developed. Permanent bleeding into the gastro-
intestinal tract has to be confirmed by a faecal occult
blood test as there is usually no massive haemorrhage.
Nausea, vomiting, flatulence and abdominal pain are
often devaluated and delay a diagnosis [2].
In the presented case, the main complaint was recur-
rent abdominal pain diagnosed by a general practitioner
(GP) as gastroenteritis and treated with a muscle relax-
ant and stomach protective drugs. There were no signs
of a subileal or abdominal mass on palpation; therefore,
a GP decided to send the patient for further tests when
no recovery was observed. Intussusception was not
suspected.
It is worth mentioning that intussusception was de-
scribed for the first time in 1674, and successful oper-
ation in a child was performed in 1871 [15]. This
disease is the most common in infants between the
age of 5 and 10 months. It is the second leading
cause of ‘acute abdomen’ in children following appen-
dicitis. Morbidity in adults is estimated to be around
two to three cases per 1,000,000 per year. Intussus-
ception accounts for about 1 % of ileal and 0.08 % of
all surgical interventions. Otherwise, 60 % of all adult
patients suffering from the disease require emergency
operation [16]. Intussusception is usually caused by
neoplasms, adhesions or diverticula [16, 17]. A phys-
ical examination is usually difficult. Ultrasonography and
computer tomography seem to be radiological tests of
choice, with CT scan sensitivity of about 70–88 % and spe-
cificity of 100 % [16, 18]. Despite this, a proper preopera-
tive diagnosis is made in only about 35–50 % of all cases
with intussusception confirmed latter by a laparoscopy or
laparotomy [19–21].
With regard to our imaging tests, both CT and
MRI scans did not confirm any diagnosis, and the
only findings included suspected metastases in the
liver. It is worth highlighting that, due to clinical
signs before admission, probably, intussusception and
suboclusion occured and reduced spontaneously many
times what caused investigation difficulties. A colon-
oscopy confirmed the presence of a tumour, but
wrong localisation on Bauhin’s valve was described.
Histopathological findings from colonoscopy samples
were also not diagnostic with regard to a type of a
neoplasm. The patient was qualified for a laparoscopy
in order to perform right hemicolectomy as a caecal
tumour was suspected in a preoperative examination.
During a surgery, when intussusception of the ileum
into the caecum was diagnosed and a small bowel
tumour was confirmed, we had to change an operat-
ing procedure into an ileal resection.
Laparoscopy procedures in case of smooth muscle
neoplasms are rare. As a result of searching the PubMed
database, only one case of a segmental laparoscopic re-
section of the small bowel due to a leiomyosarcoma de-
scribed by Hamm et al. in 2013 was found [22]. These
neoplasms rarely give lymph nodes metastases, and ad-
vanced lymphadenectomy in these operations is usually
not required. It is possible to perform minimally invasive
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treatment such as a laparoscopy instead of laparotomy
[1, 13]. A laparoscopy in GI tumours used to be per-
formed as a safe and acceptable method of colorectal
cancer (CRC) treatment. Between 1997 and 2003, the
COLOR study was conducted in seven EU countries
(COLon cancer Laparoscopic or Open Resection) involv-
ing 29 hospitals. There were no differences in an open
versus laparoscopic approach with regard to tumour sta-
ging, localisation, diameter, histological type, lymph
nodes resected/metastasised and R1/R2 resection
(microscopic/macroscopic non-curative resection) [23].
Another multicentre study (48 centres) involving over
870 patients suffering from CRC confirmed the same re-
currence rate for both types of a surgery [24]. A retro-
spective analysis of over 430 patients operated at the
Cleveland Clinic between 1996 and 2007 revealed the
same rate of all resected lymph nodes and a higher rate
of metastasised lymph nodes after a laparoscopic resec-
tion compared to an open access [25].
When compared to the results of other reports con-
cerning colon cancer treatment, our report demonstrates
that a laparoscopic resection of small bowel sarcomas
may be a reasonable and safe alternative to a usually per-
formed open resection.
As it was already mentioned with regard to current
histopathological classification, smooth muscle neo-
plasms are very rare—gastrointestinal stromal tu-
mours are predominantly diagnosed. Proper
differentiation between these two types of STSs is
very important to select appropriate adjuvant therapy.
In some cases, leiomyosarcomas can be treated by
conventional chemotherapy, whereas GIST therapy re-
quires different drugs such as imatinib—a tyrosine
kinase inhibitor [4, 26]. In LMS treatment, efficacy of
adjuvant chemotherapy is limited. Tumours are also
resistant to radiotherapy [1]. With regard to the most
active drugs used in STS therapy, namely doxorubicin
and ifosfamide, the response rates around 15–20 %
can be achieved. New agents, such as trabectedin with
gemcitabin or pazopanib, are unsatisfactory yet. Cur-
rently, there are no recommendations whether to use
these agents in STS treatment [27].
Conclusions
Chronic recurrent cramp-like abdominal pain can be
caused by serious gastrointestinal disease and often
requires endoscopic investigation, especially in elderly
patients. Intussusception in these cases might not be
permanent; it occurs and reduces spontaneously but
recurs. This can cause diagnostic problems and delays
final diagnosis. A surgical resection, also by laparos-
copy, is the treatment of choice and allows a patient
to benefit from adjuvant therapy.
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